1. Home
  2. EVO vs SDHC Comparison

EVO vs SDHC Comparison

Compare EVO & SDHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • SDHC
  • Stock Information
  • Founded
  • EVO 1993
  • SDHC 2008
  • Country
  • EVO Germany
  • SDHC United States
  • Employees
  • EVO N/A
  • SDHC N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • SDHC
  • Sector
  • EVO Health Care
  • SDHC
  • Exchange
  • EVO Nasdaq
  • SDHC Nasdaq
  • Market Cap
  • EVO 1.6B
  • SDHC 1.3B
  • IPO Year
  • EVO 2021
  • SDHC 2024
  • Fundamental
  • Price
  • EVO $4.44
  • SDHC $23.67
  • Analyst Decision
  • EVO Buy
  • SDHC Hold
  • Analyst Count
  • EVO 2
  • SDHC 5
  • Target Price
  • EVO $5.90
  • SDHC $29.60
  • AVG Volume (30 Days)
  • EVO 46.1K
  • SDHC 70.8K
  • Earning Date
  • EVO 11-06-2024
  • SDHC 03-12-2025
  • Dividend Yield
  • EVO N/A
  • SDHC N/A
  • EPS Growth
  • EVO N/A
  • SDHC N/A
  • EPS
  • EVO N/A
  • SDHC 4.71
  • Revenue
  • EVO $866,665,179.00
  • SDHC $905,304,000.00
  • Revenue This Year
  • EVO $3.84
  • SDHC $27.24
  • Revenue Next Year
  • EVO $10.94
  • SDHC $9.97
  • P/E Ratio
  • EVO N/A
  • SDHC $5.02
  • Revenue Growth
  • EVO N/A
  • SDHC 17.46
  • 52 Week Low
  • EVO $2.85
  • SDHC $20.55
  • 52 Week High
  • EVO $7.98
  • SDHC $39.50
  • Technical
  • Relative Strength Index (RSI)
  • EVO 49.82
  • SDHC 45.89
  • Support Level
  • EVO $4.40
  • SDHC $22.75
  • Resistance Level
  • EVO $4.49
  • SDHC $24.10
  • Average True Range (ATR)
  • EVO 0.10
  • SDHC 0.98
  • MACD
  • EVO -0.00
  • SDHC 0.20
  • Stochastic Oscillator
  • EVO 38.46
  • SDHC 54.43

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About SDHC Smith Douglas Homes Corp.

Smith Douglas Homes Corp is a company engaged in the design, construction, and sale of single-family homes in some of the highest growth and desirable markets in the Southeastern United States. The company has organized into five geographical segments so their reportable segments include Atlanta, Raleigh, Charlotte, Nashville, and Alabama which consists of both Birmingham and Huntsville.

Share on Social Networks: